Alphamab's soup
China's Alphamab goes start to finish with antibodies
Chinese protein engineering company Alphamab is building a one-stop antibody production facility housing a slew of multispecific antibody-generating technologies and its own GMP plant under construction. The company has its own spin on the well-trodden territory of bispecifics production and is bringing innovation to the space with mix-mAb and nanobody platforms that can produce multiple, multifunctional antibodies in a single cell line.
According to CEO Ting Xu, Suzhou Alphamab Co. Ltd. not only plans to make a variety of antibody types but will combine antibody modules with other types of protein modules to make novel biologics. ...